FOLLICULAR HELPER T-CELL LYMPHOMA, FOLLICULAR-TYPE

Clinical trials for FOLLICULAR HELPER T-CELL LYMPHOMA, FOLLICULAR-TYPE explained in plain language.

Never miss a new study

Get alerted when new FOLLICULAR HELPER T-CELL LYMPHOMA, FOLLICULAR-TYPE trials appear

Sign up with your email to follow new studies for FOLLICULAR HELPER T-CELL LYMPHOMA, FOLLICULAR-TYPE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1

New hope for Tough-to-Treat blood cancer? early trial tests drug combo

Disease control Not yet recruiting

This early-stage trial aims to find a safe and effective dose of a drug called ruxolitinib when given alongside standard chemotherapy (CHOP) for adults newly diagnosed with a rare type of T-cell lymphoma. The main goal is to see if the combination is safe and tolerable. If patien…

Matched conditions: FOLLICULAR HELPER T-CELL LYMPHOMA, FOLLICULAR-TYPE

Phase: PHASE1 • Sponsor: City of Hope Medical Center • Aim: Disease control

Last updated Mar 12, 2026 13:51 UTC

FOLLICULAR HELPER T-CELL LYMPHOMA, FOLLICULAR-TYPE

Get alerted when new FOLLICULAR HELPER T-CELL LYMPHOMA, FOLLICULAR-TYPE trials appear

New hope for Tough-to-Treat blood cancer? early trial tests drug combo